Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study

Estrada-Alarcon, Paula; Garcia-Manrique, Maria; Gomez-Centeno, Antoni; Inciarte-Mundo, Jose; Narváez García, Francisco Javier; Pascal, Mariona; Rodríguez Moreno, Jesús; Sanmartí Sala, Raimon; Yagüe, Jordi

Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study

Authors: Paula Estrada-Alarcon
Maria Garcia-Manrique
Antoni Gomez-Centeno
Jose Inciarte-Mundo
Francisco Javier Narváez García
Mariona Pascal
Jesús Rodríguez Moreno
Raimon Sanmartí Sala
Jordi Yagüe
Publication date
Publisher: BMJ Publishing Group

Abstract

Article en format correspondènciaWe read with great interest the paper by Chen et al1 analysing the relationship between therapeutic response to adalimumab and etanercept and serum drug trough levels in 70 patients with rheumatoid arthritis (RA). ..

Similar works

Full text

Available Versions

RECERCAT

oai:recercat.cat:2072/284133

Last time updated on 05/04/2020